Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents
CONCLUSIONS: DAA treatment does not seem to be associated with HCC promotion after HCV eradication in patients with severe fibrosis stages. DAA-induced SVR is associated with a reduced estimation of fibrosis.PMID:33639690
Source: Acta Gastro-Enterologica Belgica - Category: Gastroenterology Authors: C Hamoir Y Horsmans P St ärkel G Dahlqvist S Negrin Dastis N Lanthier Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Gastroenterology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Study | Urology & Nephrology | Virology